CRL

NYSE Charles River Laboratories International, Inc.

Nov 1, 2026 · 6:45 PM ET EOD Market Closed

$359.41 ↑ +0.00 (+0.00%) Trading Up from the previous close of $359.41, $15.15 below the day’s high of $374.56

YTD change: +80.17%
vs 20-day SMA: +11.85%
vs 200-day SMA: +62.58%

Price ranges

Previous day

$351.98 $374.56

open $372.99 close $359.41

-$13.58 (-3.64%)

Today

$351.98 $374.56

$359.41

Past week

$332.17 $379.63

from $339.66 now $359.41

+$19.75 (+5.81%)

Past month

$285.75 $379.63

from $286.83 now $359.41

+$72.58 (+25.30%)

This year

$146.20 $379.63

from $199.48 now $359.41

+$159.93 (+80.17%)

Price & Performance

+193.63 (+116.80%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 21.9% away from all-time highs of $460.21
CRL is up 80% since the beginning of the year
CRL is up 101% over the past 12 months
CRL is up 25% over the past 1 month
6% of all CRL investors are betting against CRL
Number of investors short CRL has gone up 12% versus last month

CRL reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +100.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $3.02

Earnings momentum -1.6% Quarterly EPS growth

Quarterly change -1.6%

Valuation

P/E ratio N/A

Enterprise value $20.9B

Beta 1.44

Balance sheet & scale

IncomeN/A

Revenue$4.0B

Cash$216.5M

Debt$3.0M

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $17.2B

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Competitor comparison

Ticker	Company	Price	Change
REGN	Regeneron Pharmaceuticals, Inc.	$927.89	+13.33%
IQV	IQVIA Holdings Inc	$267.33	-2.81%
ICLR	ICON Plc	$211.36	-1.91%
IT	Gartner, Inc.	$228.79	+1.66%
MDGL	Madrigal Pharmaceuticals, Inc.	$430.36	-0.31%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.